PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 868-873

  Asplund, A ^a   Gustafsson, A C ^b   Wikonkal, N M ^c   Sela, A ^c   Leffell, D J ^c   Kidd, K ^c   Lundeberg, J ^a   Brash, D E ^c   Pontén, Fredrik ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eumelanin; Loss of heterozygozity; Nonmelanoma skin cancer; Phaeomelanin; PTCH; Single nucleotide polymorphism

Indexed keywords

EUMELANIN; LEUCINE; MELANIN; PHEOMELANIN; PROLINE; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; BLOOD SAMPLING; BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CODON; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; EXON; GENE FREQUENCY; GENE LOSS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAIR COLOR; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MICRODISSECTION; ONSET AGE; PHENOTYPE; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTCH GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN PIGMENTATION; SQUAMOUS CELL CARCINOMA; SWEDEN; TUMOR SUPPRESSOR GENE; UNITED STATES;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CODON; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAIR COLOR; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 18944373538     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06464.x     Document Type: Article

References (36)

1. Cargill M, Altshuler D, Ireland J et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-8.
2. Shen H, Liu Z, Strom SS et al. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol 2003; 121:1510-4.
3. Chang-Claude J, Dunning A, Schnitzbauer U et al. The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk. Int J Cancer 2003; 103:779-83.
4. http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=357564.
5. Ko CB, Walton S, Keczkes K et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130:269-72.
6. Farndon PA, Del Mastro RG, Evans DG et al. Location of gene for Gorlin syndrome. Lancet 1992; 339:581-2.
7. Gailani MR, Bale SJ, Leffell DJ et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992; 69:111-7.
8. Kim MY, Park HJ, Baek SC et al. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002; 29:1-9.
9. Ratner D, Peacocke M, Zhang H et al. UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun-exposed skin. J Am Acad Dermatol 2001; 44:293-7.
10. Dybdahl M, Vogel U, Frentz G et al. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 1999; 8:77-81.
11. Box NF, Duffy DL, Irving RE et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001; 116:224-9.
12. Vogel U, Hedayati M, Dybdahl M et al. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001; 22:899-904.
13. Nilsson M, Undén AB, Krause D et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA 2000; 97:3438-43.
14. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001; 10:757-62.
15. Ping XL, Ratner D, Zhang H et al. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol 2001; 116:614-6.
16. Ahmadian A, Ren ZP, Williams C et al. Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma. Oncogene 1998; 17:1837-44.
17. Aszterbaum M, Epstein J, Oro A et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999; 5:1285-91.
18. Koike C, Mizutani T, Ito T et al. Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431. Oncogene 2002; 21:2670-8.
19. Xie J, Johnson RL, Zhang X et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 1997; 57:2369-72.
20. Calzada-Wack J, Schnitzbauer U, Walch A et al. Analysis of the PTCH coding region in human rhabdomyosarcoma. Hum Mutat 2002; 20:233-4.
21. Taipale J, Beachy PA. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001; 411:349-54.
22. Fan H, Khavari PA. Sonic hedgehog opposes epithelial cell cycle arrest. J Cell Biol 1999; 147:71-6.
23. Hasenpusch-Theil K, Bataille V, Laehdetie J et al. Gorlin syndrome: identification of 4 novel germ-line mutations of the human patched (PTCH) gene. Mutations in brief no. 137. Online. Hum Mutat 1998; 11:480.
24. Rost B, Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 1993; 232:584-99.
25. Rost B, Sander C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 1994; 19:55-72.
26. Tishkoff SA, Dietzsch E, Speed W et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996; 271:1380-7.
27. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88:10124-8.
28. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on real-time pyrophosphate. Science 1998; 281 (363):365.
29. Cavalli-Sforza L, Menozzi P, Piazza A. History and Geography of Human Genes. Princeton: Princeton University Press, 1994.
30. Long CC, Marks R. Increased risk of skin cancer: another Celtic myth? A review of Celtic ancestry and other risk factors for malignant melanoma and nonmelanoma skin cancer. J Am Acad Dermatol 1995; 33:658-61.
31. Gailani MR, Stahle-Backdahl M, Leffell DJ et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996; 14:78-81.
32. Chedekel MR, Smith SK, Post PW et al. Photodestruction of pheomelanin: role of oxygen. Proc Natl Acad Sci USA 1978; 75:5395-9.
33. Hill HZ, Li W, Xin P et al. Melanin: a two edged sword? Pigment Cell Res 1997; 10:158-61.
34. Johnson RL, Milenkovic L, Scott MP. In vivo functions of the patched protein: requirement of the C terminus for target gene inactivation but not Hedgehog sequestration. Mol Cell 2000; 6:467-78.
35. Bailey EC, Milenkovic L, Scott MP et al. Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts. J Biol Chem 2002; 277:33632-40.
36. Eklund LK, Holmberg E, Undén AB et al. Mutation analysis of the human homologue of Drosophila patched (PTCH) and the xeroderma pigmentosum complementation group A (APA) genes in squamous cell carcinomas of the skin. Mol Carcinog 1998; 21:87-92.